Patents Assigned to Brook Biotechnology, Inc.
  • Groups of and that cause Lyme Disease in humans
    Patent number: 7582304
    Abstract: The present invention is drawn to an immunogenic composition comprising OspC polypeptides from Lyme Disease causing Borrelia. In one embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia burgdorferi OspC families A, B, I and K. In another embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia afzelii OspC families A and B.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: September 1, 2009
    Assignees: Research Foundation of the State University of New York, Brook Biotechnologies, Inc.
    Inventors: Raymond J. Dattwyler, Gerald Seinost, Daniel Dykhuizen, Benjamin J. Luft, Maria J. C. Gomes-Solecki
  • Groups Of Borrelia Burgdorferi And Borrelia Afzelii That Cause Lyme Disease In Humans
    Publication number: 20090060932
    Abstract: The present invention is drawn to an immunogenic composition comprising OspC polypeptides from Lyme Disease causing Borrelia. In one embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia burgdorferi OspC families A, B, I and K. In another embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia afzelii OspC families A and B.
    Type: Application
    Filed: March 9, 2006
    Publication date: March 5, 2009
    Applicants: Research Foundation of the State University of New York, Brook Biotechnologies, Inc.
    Inventors: Raymond Dattwyler, Gerald Seinost, Daniel Dykhuizen, Benjamin Luft, Maria Gomes-Solecki
  • Groups of and that cause lyme disease in humans
    Patent number: 7060281
    Abstract: The present invention is drawn to an immunogenic composition comprising OspC polypeptides from Lyme Disease causing Borrelia. In one embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia burgdorferi OspC families A, B, I and K. In another embodiment, the immunogenic composition of the present invention comprises at least one OspC polypeptide or immunogenic fragment thereof from each of Borrelia afzelii OspC families A and B.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: June 13, 2006
    Assignees: Research Foundation of the State University of New York, Brook Biotechnology, Inc.
    Inventors: Raymond J. Dattwyler, Gerald Seinost, Daniel Dykhuizen, Benjamin J. Luft, Maria J. C. Gomes-Solecki